Healthy adults
Conditions
Interventions
Duration: 8 weeks Test material: Boswellin Super 300 mg One tablet per day (300 mg/day)
Duration: 8 weeks Test material: 449 mg One tablet per day (449 mg/day)
Duration: 8 weeks Test material: 44
Sponsors
ORTHOMEDICO Inc.
Seishin-kai Medical Association Inc, Takara Medical Clinic.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: a) Healthy adults, who have knee joint pain b) Persons who are 60s, 50s, 40s, 30s and 20s
Exclusion criteria
Exclusion criteria: a) Persons who have previous medical history of malignant tumor, or heart failure and/or myocardial infarction b) Patients being treated for at least one of following diseases atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, and/or other chronic disease c) Persons who take medicines, herbal medicines, or dietary supplements d) Persons who are allergic to medicines, or foods related to the test material of this trial e) Pregnant women, lactating women, or women who want to get pregnant during the trial period f) Persons who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial g) Persons who are judged not suitable to participate in this trial by physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Questionnaires (JKOM) | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Hyarulonic acid Serum hs-CRP Questionnaires (Likert scale) Questionnaires (WOMAC) Blood test Urianalysis Physical examinations | — |
Countries
Japan
Contacts
Public ContactNaoko SUZUKI
ORTHOMEDICO, Inc. R&D Department
Outcome results
None listed